Coree S.r.l., Piazza San Babila 5, 20122 Milan, Italy; Department for Sustainable Food Processes, Università Cattolica del Sacro Cuore, Via Emilia Parmense, 84, 29122 Piacenza, Italy.
Department for Sustainable Food Processes, Università Cattolica del Sacro Cuore, Via Emilia Parmense, 84, 29122 Piacenza, Italy.
Food Res Int. 2021 Apr;142:110216. doi: 10.1016/j.foodres.2021.110216. Epub 2021 Feb 13.
Oat (Avena sativa L.) is widely appreciated for its beneficial properties for human health, which have led to the introduction of more food products on the market, including oat beverages. The fibre components found in the oat are recognized for their beneficial effects, despite other bioactive compounds with healthy properties being present. This work aimed to evaluate the metabolites profile of a commercial oat beverage, either fermented with lactic bacteria or not, following in vitro gastro-intestinal digestion. UHPLC-QTOF untargeted metabolomics allowed investigation of the bioaccessibility of health-related metabolites from the oat beverage at the intestinal level. The results identified flavonoids, phenolic acids (avenanthramides), amino acids and steroids as the major classes of compounds. In particular, after in vitro digestion, amino acids, peptides, and phenolic acids showed the highest increases. The co-fermentation of oat milk by Lactobacillus spp. and Bifidobacterium spp. strains decreased the levels of both lignans and phytic acid, while increased the levels of some polyphenols like avenanthramides. Furthermore, fermentation by microorganisms increased the bioaccessibility of specific amino acids, vitamins, and polyphenols (flavonoids and phenolic acids). Interestingly, despite lacking a significant part of beta-glucans, the HPAEC-PAD profiling of our oat beverage evidenced that the fermentation process did not alter the oligosaccharides profile, thus preserving its prebiotic potential. The phytochemical profile of oat milk was shown to have a functional potential. Nonetheless, the fermentation by bacterial strains changed the profile of metabolites during in vitro digestion, thus offering an interesting option in the future development of cereal-based beverages.
燕麦(Avena sativa L.)因其对人类健康的有益特性而广受欢迎,这导致市场上推出了更多的食品产品,包括燕麦饮料。燕麦中的纤维成分因其有益作用而被认可,尽管存在其他具有健康特性的生物活性化合物。本工作旨在评估商业燕麦饮料的代谢物谱,该饮料要么经过乳酸细菌发酵,要么不发酵,随后进行体外胃肠消化。UHPLC-QTOF 非靶向代谢组学允许研究与健康相关的代谢物在肠道水平的生物利用度。结果确定了类黄酮、酚酸(燕麦酰胺)、氨基酸和甾体作为主要化合物类别。特别是,在体外消化后,氨基酸、肽和酚酸显示出最高的增加。通过 Lactobacillus spp. 和 Bifidobacterium spp. 菌株共发酵燕麦奶降低了木质素和植酸的水平,同时增加了一些多酚类物质(如燕麦酰胺)的水平。此外,微生物发酵增加了特定氨基酸、维生素和多酚类物质(类黄酮和酚酸)的生物利用度。有趣的是,尽管缺乏大量的β-葡聚糖,但我们的燕麦饮料的 HPAEC-PAD 分析表明发酵过程并未改变低聚糖谱,从而保留了其益生元潜力。燕麦奶的植物化学物质谱显示出具有功能潜力。尽管如此,细菌菌株的发酵在体外消化过程中改变了代谢物的谱,因此为未来开发基于谷物的饮料提供了一个有趣的选择。